Product
NAN-101
1 clinical trial
9 indications
Indication
Heart FailureIndication
Congestive Heart FailureIndication
Heart diseaseIndication
IschemicIndication
Cardiovascular DiseasesIndication
systolicIndication
ArrhythmiaIndication
diastolicIndication
Heart ComplicationsClinical trial
Phase 1 Open Label, Dose Escalation Trial of Intracoronary Infusion of NAN-101 in Subjects With NYHA Class III Heart FailureStatus: Recruiting, Estimated PCD: 2026-12-31